Does genetic variance in the serotonergic system contribute to pain and the efficacy of drug that blocks serotonin?
Phase 1
- Conditions
- Experimentally induced muscle pain in healthy volunteers, both sexes and over 18 years of age.Therapeutic area: Body processes [G] - Biological Phenomena [G16]
- Registration Number
- EUCTR2011-006206-27-SE
- Lead Sponsor
- Karolinska Institutet
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Good general health
Age > 18 years
No current facial pain
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 70
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Systemic inflammatory connective tissue diseases
whiplash-associated disorder
fibromyalgia
neuropathic pain or neurological disorders
use of analgesics
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method